Active substancePegaptanibPegaptanib Similar drugsTo uncover Makugen solution for injections Dosage form: & nbspSolution for injection into the vitreous Composition:Active substance: pegaptanib sodium - 0.3 mg;Excipients: sodium dihydrogen phosphate monohydrate, sodium hydrogen phosphate heptahydrate, sodium chloride, hydrochloric acid, sodium hydroxide, water. ATX: & nbspS.01.L.A.03 Pegaptanib Indications:Age-related macular degeneration is a neovascular form (wet). Contraindications:Hypersensitivity to the components of the drug.Eye / periocular infectionChildhood.Pregnancy. With caution, the drug is prescribed during breastfeeding. Pregnancy and lactation:Contraindicated. Dosing and Administration:Makugzhen injected into the vitreous body for one dose every 6 weeks, up to 9 injections per year. The injection into the vitreous body is authorized by an ophthalmologist who has sufficient experience in administering intravitreal injections strictly in sterile conditions with concomitant anesthesia. Overdose:no data. Interaction:no data. Form release / dosage:Solution for intravitreal administration. Packaging:Syringe for injection 90 mcg in a pack of cardboard with instructions. Terms of leave from pharmacies:On prescription Illustrated instructions × Illustrated instructions Instructions